Assessment | Enrolment | Study in-progress | Study end | |||
---|---|---|---|---|---|---|
Baseline | Hospital discharge | 24h | 1Week | 1 month | 3 months | |
Eligibility screen | A | Â | Â | Â | Â | Â |
COACHeD Brief Assessment of Capacity to Consent | B | Â | Â | Â | Â | Â |
Informed consent | 1/C | Â | Â | Â | Â | Â |
Coordination Continuity of Care Questionnaire (CCCQ) | I/C | Â | Â | Â | Â | I/C |
EQ-5D-5L v10-Canada | 1/C | Â | Â | Â | Â | I/C |
OAC knowledge test | I/C | Â | Â | Â | Â | I/C |
Randomization and allocation | I/C | Â | Â | Â | Â | Â |
Discharge medication reconciliation and management, circle of care communication and coordination | Â | I | Â | Â | Â | Â |
Virtual Visit Call #1 | Â | Â | I | Â | Â | Â |
Virtual Visit Call #2 | Â | Â | Â | I | Â | Â |
Virtual Visit Call #3 | Â | Â | Â | Â | I | Â |
Adverse anticoagulant safety events (AASE) | Â | Â | Â | Â | Â | I/C |
AASE individual components | Â | Â | Â | Â | Â | I/C |
Patient/Caregiver Satisfaction Questionnaire | Â | Â | Â | Â | Â | I/C |
Provider Satisfaction Questionnaire | Â | Â | Â | Â | Â | I/C |
Health Resource Utilization Questionnaire | Â | Â | Â | Â | Â | I/C |
Medication-related problems | Â | Â | Â | Â | Â | I/C |